News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Evogene Ltd. (EVGN) Announces Amendment To Bayer Wheat Agreement To Focus On Discovery Of Novel Genomic Promoters



7/24/2014 11:38:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

REHOVOT, Israel--(BUSINESS WIRE)--Evogene Ltd. (NYSE, TASE:EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, today announced an amendment to the remaining work plan under its collaboration with Bayer CropScience LP (Bayer) for improved wheat. Pursuant to the amended work plan, Evogene will shift from discovery of additional genes and SNP’s to discovery of novel genomic promoters.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES